Arkolith/Insider Trading/GALT/Form 4

Callicutt Jack W

Chief Financial OfficerGALECTIN THERAPEUTICS INC (GALT) · full profile →Form 4 · filed Jan 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$233K
Net Open-Market Flow
-$233K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 6, 2026Sell(S)20K$3.67$75K8K
Jan 5, 2026Sell(S)26K$3.90$100K28K
Jan 2, 2026Option exercise(M)60K—$068K
Jan 2, 2026Sell(S)14K$4.20$58K54K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 1, 2026Option exercise(M)60K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001133416-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML